MedPath

Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease

Not Applicable
Recruiting
Conditions
Pulmonary Disease, Chronic Obstructive (COPD)
Registration Number
NCT07177976
Lead Sponsor
Foundation University Islamabad
Brief Summary

Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.

Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management

Detailed Description

Chronic Obstructive pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratory condition may lead to shallow breathing.

Breathing exercises help to manage hyperventilation often seen in copd patients. To handle respiratory complications patients are advised to practice brathing techniques along with pharmacological management.

Total 46 participants are allocated divided into two group. Group A will perform Pilates breathing along with pharmacological management and group B will perform Pursed-lip breathing along with pharmacological management.

Hence objective of study is to compare the effects of pilates breathing techniques along with pharmacological management versus pursed-lip breathing along with pharmacological management on chest expansion, peak expiratory flow rate, dyspnea and quality of life in patients with chronic obstructive lung disease

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Age between 40-64 years
  • Both genders (male and female)
  • Grade 1-3 on mMRC scale of dyspnea
  • COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted
Exclusion Criteria
  • Moderate, severe and very severe stage of COPD according to GOLD classification
  • Patients having acute exerbation of COPD
  • Patients diagnosed with acute infection
  • Patients unable to follow command and instructions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Chest Expansion03 weeks

Evaluation will be done using inch tape (inches) for Chest Expansion

Peak expiratory flow rate03 weeks

Evaluation will be done by using Peak flow meter

Dyspnea03 weeks

Evaluation will be done by using Modified Medical Research Council Dyspnea Scale (mMRC)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Foundation University College of Physical Therapy, Islamabad, 44000

🇵🇰

Rawalpindi, Pakistan

Foundation University College of Physical Therapy, Islamabad, 44000
🇵🇰Rawalpindi, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.